GAAP earnings miss consensus. HealthEquity, Inc. (HQY) reported GAAP diluted EPS of $0.58 for Q4 fiscal 2026, missing the analyst consensus of $0.90 by 35.4%. The health information services provider posted adjusted EPS of $0.95, which also fell short of expectations. Net income came in at $49.7 million, while adjusted net income reached $81.8 million with adjusted EBITDA of $132.9 million. The shortfall marks a departure from the company’s recent track record of consecutive earnings beats in prior quarters.
Revenue edges past estimates. Revenue of $334.6 million topped the consensus estimate of $332.8 million by 0.5%, representing 7.3% growth versus the year-ago quarter’s $311.8 million. The top-line performance reflects sequential stability, matching Q3 2026’s $334.6 million result. Despite the revenue beat, the 42.6% year-over-year decline in GAAP EPS from $1.01 in Q4 2025 suggests margin pressure or elevated expenses that offset the revenue expansion.
Fiscal 2027 guidance in focus. Management issued fiscal 2027 guidance calling for GAAP EPS of $2.78 to $2.85 on revenue of $1.41 billion to $1.42 billion. The Street’s 15 analysts maintain a bullish stance with 14 Buy or Strong Buy ratings against just one Sell. The stock closed at $77.81, trading well below its 52-week high of $116.65.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.